A display of pH-sensitive fusogenic GALA peptide facilitates endosomal escape from a Bio-nanocapsule via an endocytic uptake pathway

Journal of Nanobiotechnology

Volumn 12, Issue 1, 2014, Pages

  Nishimura, Yuya ^a   Takeda, Koichi ^a   Ezawa, Ryosuke ^a   Ishii, Jun ^a   Ogino, Chiaki ^a   Kondo, Akihiko ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Bio nanocapsule; Drug delivery; Endosomal escape; GALA; HER2; pH sensitive peptide

Indexed keywords

CELLS; CYTOLOGY; DRUG DELIVERY; MOLECULAR BIOLOGY; NANOCAPSULES; VIRUSES;

BIO NANOCAPSULES; ENDOSOMAL ESCAPES; GALA; HER2; PH SENSITIVE;

PEPTIDES;

1,2 DIOLEOYL SN GLYCERO 3 PHOSPHOETHANOLAMINE; BIO NANOCAPSULE; DIHYDROLIPOAMIDE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GALA PEPTIDE; GLYCEROPHOSPHOETHANOLAMINE; HEPATITIS B SURFACE ANTIGEN; NANOCAPSULE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ARTICLE; CELL INCLUSION; CELL VIABILITY; CIRCULAR DICHROISM; CYTOPLASM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; ENDOSOME; HUMAN; HUMAN CELL; LIPID BILAYER; MEMBRANE FUSION; NONHUMAN; PH; VIRUS LIKE AGENT; YEAST;

AMINO ACID SEQUENCE; CELL LINE; ENDOCYTOSIS; HEPATITIS B SURFACE ANTIGENS; HUMANS; HYDROGEN-ION CONCENTRATION; MOLECULAR SEQUENCE DATA; NANOCAPSULES; PEPTIDES; RECOMBINANT FUSION PROTEINS;

EID: 84899870413     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-12-11     Document Type: Article

References (21)

1. Wang Y, Mangipudi SS, Canine BF, Hatefi A. A designer biomimetic vector with a chimeric architecture for targeted gene transfer. J Control Release 2009, 137(1):46-53. 10.1016/j.jconrel.2009.03.005, 2925643, 19303038.
2. Wang T, Yang S, Petrenko VA, Torchilin VP. Cytoplasmic delivery of liposomes into MCF-7 breast cancer cells mediated by cell-specific phage fusion coat protein. Mol Pharm 2010, 7(4):1149-1158. 10.1021/mp1000229, 2914188, 20438086.
3. Lear JD, DeGrado WF. Membrane binding and conformational properties of peptides representing the NH2 terminus of influenza HA-2. J Biol Chem 1987, 262(14):6500-6505.
4. Goormaghtigh E, De Meutter J, Szoka F, Cabiaux V, Parente RA, Ruysschaert JM. Secondary structure and orientation of the amphipathic peptide GALA in lipid structures. An infrared-spectroscopic approach. Eur J Biochem 1991, 195(2):421-429. 10.1111/j.1432-1033.1991.tb15721.x, 1997324.
5. Futaki S, Masui Y, Nakase I, Sugiura Y, Nakamura T, Kogure K, Harashima H. Unique features of a pH-sensitive fusogenic peptide that improves the transfection efficiency of cationic liposomes. J Gene Med 2005, 7(11):1450-1458. 10.1002/jgm.796, 16025556.
6. Kuroda S, Otaka S, Miyazaki T, Nakao M, Fujisawa Y. Hepatitis B virus envelope L protein particles. Synthesis and assembly in Saccharomyces cerevisiae, purification and characterization. J Biol Chem 1992, 267:1953-1961.
7. Yamada T, Iwasaki Y, Tada H, Iwabuki H, Chuah MK, VandenDriessche T, Fukuda H, Kondo A, Ueda M, Seno M, Tanizawa K, Kuroda S. Nanoparticles for the delivery of genes and drugs to human hepatocytes. Nat Biotechnol 2003, 21:885-890. 10.1038/nbt843, 12833071.
8. Kasuya T, Jung J, Kadoya H, Matsuzaki T, Tatematsu K, Okajima T, Miyoshi E, Tanizawa K, Kuroda S. In vivo delivery of bionanocapsules displaying Phaseolus vulgarisAgglutinin-L4 isolectin to malignant tumors overexpressing N-acetylglucosaminyltransferase V. Human Gene Therapy 2008, 19:887-895. 10.1089/hum.2008.037, 18717644.
9. Shishido T, Azumi Y, Nakanishi T, Umetsu M, Tanaka T, Ogino C, Fukuda H, Kondo A. Biotinylated bionanocapsules for displaying diverse ligands toward cell-specific delivery. J Biochem 2009, 146:867-874. 10.1093/jb/mvp134, 19710034.
10. Shishido T, Yonezawa D, Iwata K, Tanaka T, Ogino C, Fukuda H, Kondo A. Construction of arginine-rich peptide displaying bionanocapsules. Bioorg Med Chem Lett 2009, 19:1473-1476. 10.1016/j.bmcl.2009.01.049, 19200722.
11. Shishido T, Mieda H, Hwang SY, Nishimura Y, Tanaka T, Ogino C, Fukuda H, Kondo A. Affibody-displaying bionanocapsules for specific drug delivery to HER2-expressing cancer cells. Bioorg Med Chem Lett 2010, 20:5726-5731. 10.1016/j.bmcl.2010.08.011, 20801029.
12. Orlova A, Magnusson M, Eriksson TL, Nilsson M, Larsson B, Hoiden-Guthenberg I, Widstrom C, Carlsson J, Tolmachev V, Stahl S, Nilsson FY. Tumor imaging using a picomolar affinity HER2 binding affibody molecule. Cancer Res 2006, 66:4339-4348. 10.1158/0008-5472.CAN-05-3521, 16618759.
13. Lee SB, Hassan M, Fisher R, Chertov O, Chernomordik V, Kramer-Marek G, Gandjbakhche A, Capala J. Affibody molecules for in vivo characterization of HER2-positive tumors by near-infrared imaging. Clin Cancer Res 2008, 14:3840-3849. 10.1158/1078-0432.CCR-07-4076, 3398736, 18559604.
14. Nishimura Y, Ishii J, Okazaki F, Ogino C, Kondo A. Complex carriers of affibody-displaying bio-nanocapsules and composition-varied liposomes for HER2-expressing breast cancer cell-specific protein delivery. J Drug Target 2012, 20(10):897-905. 10.3109/1061186X.2012.725404, 23020553.
15. Nishimura Y, Mieda H, Ishii J, Ogino C, Fujiwara T, Kondo A. Targeting cancer cell-specific RNA interference by siRNA delivery using a complex carrier of affibody-displaying bio-nanocapsules and liposomes. J Nanobiotechnology 2013, 11:19. 10.1186/1477-3155-11-19, 3699380, 23800313.
16. Nishimura Y, Takeda K, Ishii J, Ogino C, Kondo A. An affinity chromatography method used to purify His-tag-displaying bio-nanocapsules. J Virol Methods 2013, 189(2):393-396. 10.1016/j.jviromet.2013.03.008, 23523889.
17. Jung J, Matsuzaki T, Tatematsu K, Okajima T, Tanizawa K, Kuroda S. Bio-nanocapsule conjugated with liposomes for in vivo pinpoint delivery of various materials. J Control Release 2008, 126:255-264. 10.1016/j.jconrel.2007.12.002, 18207275.
18. Davison Z, Blacquiere GE, Westley BR, May FEB. Insulin-like growth factor-dependent proliferation and survival of triple-negative breast cancer cells: implication for therapy. Neoplasia 2011, 13:504-515. 3114244, 21677874.
19. Jia LT, Zhang LH, Yu CJ, Zhao J, Xu YM, Gui JH, Jin M, Ji ZL, Wen WH, Wang CJ, Chen SY, Yang AG. Specific tumoricidal activity of a secreted proapototic protein consisting of HER2 antibody and constitutively active caspase-3. Cancer Res 2003, 63:3257-3262.
20. Sasaki K, Kogure K, Chaki S, Nakamura Y, Moriguchi R, Hamada H, Danev R, Nagayama K, Futaki S, Harashima H. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives. Anal Bioanal Chem 2008, 391(8):2717-2727. 10.1007/s00216-008-2012-1, 18351325.
21. Kakudo T, Chaki S, Futaki S, Nakase I, Akaji K, Kawakami T, Maruyama K, Kamiya H, Harashima H. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system. Biochemistry 2004, 43(19):5618-5628. 10.1021/bi035802w, 15134436.